With a bold prediction that interim data on its COVID-19 shot would be in the public’s hands by October, all eyes have been on Pfizer and CEO Albert Bourla. But with just days to go before November, those data still aren’t available—and Pfizer is holding on to hope that it can still roll out the… Read More »
I’m retired and 65, and usually take on seasonal retail work. The extra cash gives me a nice boost for the holidays. I’m worried employers won’t consider me due to my age, given the COVID situation. I know they can’t normally discriminate, but can they use that as an excuse not to hire me? My… Read More »
Dive Brief: The Food and Drug Administration has granted a full approval to Gilead’s COVID-19 drug Veklury, making it the first medicine to win a standard clearance from the agency to treat the disease caused by the new coronavirus. The FDA authorized Veklury for emergency use in May, a declaration that’s only valid during a… Read More »
Universal mask use could prevent nearly 130,000 deaths from Covid-19, the illness caused by the coronavirus, in the United States through next spring, scientists reported on Friday. The findings follow an assertion by Dr. Scott W. Atlas, the president’s science adviser, that masks are ineffective, in a tweet later taken down by Twitter for spreading… Read More »
The COVID-19 pandemic has disrupted nearly every aspect of healthcare, from worker protections to hospital capacity systems to supply chain management. But the sheer overwhelming nature of the crisis has caused some other important storylines to receive less attention than they would in a pre-pandemic world. Some movement is occurring despite the threat of the… Read More »